000 01141 a2200313 4500
005 20250514212411.0
264 0 _c20050203
008 200502s 0 0 eng d
022 _a0021-5155
024 7 _a10.1007/s10384-004-0110-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrierson, Ian
245 0 0 _aLatanoprost and pigmentation.
_h[electronic resource]
260 _bJapanese journal of ophthalmology
_c
300 _a602-12 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntihypertensive Agents
_xadverse effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aIris
_xdrug effects
650 0 4 _aIris Diseases
_xchemically induced
650 0 4 _aLatanoprost
650 0 4 _aPigmentation Disorders
_xchemically induced
650 0 4 _aProstaglandins F, Synthetic
_xadverse effects
700 1 _aJonsson, Monica
700 1 _aCracknell, Kathryn
773 0 _tJapanese journal of ophthalmology
_gvol. 48
_gno. 6
_gp. 602-12
856 4 0 _uhttps://doi.org/10.1007/s10384-004-0110-y
_zAvailable from publisher's website
999 _c15277084
_d15277084